STIMULAN® Rapid Cure can now be used with both a wider range of antibiotics and also with antifungals in India STIMULAN® Rapid Cure can be placed in bone and surrounding soft tissue to assist in wound healing and treatment of infection Keele, UK, 25 November 2025 – Biocomposites, an international medical devices company that engineers, […]
Randomised, double-blinded, controlled BIG D-FOOT study demonstrates that local antibiotic delivery using STIMULAN® significantly reduces post-surgical infective complications in patients with diabetic foot osteomyelitis (DFO) Biocomposites symposium will explore best practice treatment strategies for complex infections and share findings from the BIG D FOOT study Keele, UK, 9 September 2025 – Biocomposites, an international medical […]
Additional investment and resources will accelerate Biocomposites’ international expansion and innovation in products for use in infection management HELLERUP, DENMARK, LONDON and KEELE, UK – 3 March 2025 – Novo Holdings and TA Associates (“TA”), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites (“the Company”), […]
InfectoSynovia is being developed to provide a high-accuracy bedside test that can diagnose PJI in less than five minutes It is based on InfectoTest’s ability to detect the infection in tiny quantities of synovial fluid using a unique method of electrochemical analysis The investment signifies Biocomposites’ ongoing commitment to providing products for the management of […]
BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitis BLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcers Keele, UK, 7 February 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management […]
